Surge in serotonin points to new treatment target for schizophrenia

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has provided the first direct evidence that schizophrenia is associated with a greater release of serotonin in the frontal cortex, and demonstrates its link to a greater severity of some of the most disabling symptoms of the disorder.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup